Radient Pharmaceuticals Corporation fka RXPC

[guardiangel]

Sunny...GREat developments going as planned per Radient/ AMDL Diagnostics Inc. and ProvistaDx/GCDX/Uni-Pharma agreements.....Even living agrees with his latest post..We are now waiting for Radient/ProvistaDx/GCDX....And the planned reverse merger..

livinginsv Sunday, 07/26/15 10:51:34 PM
Re: guardiangel post# 29592
Post # of 29593

"no waiting on UNI . . .

it looks like their doing fine . ."

This License Agreement (the “Agreement”), which shall be effective as of June 6, 2013, is by and between Uni Pharma Co., Ltd., a Taipei, Taiwan limited liability company (“UNI”) and Radient Pharmaceuticals Corporation (including its subsidiary AMDL Diagnostics Inc.) a Delaware incorporated United States company (“RXPC”).

http://www.sec.gov/Archives/edgar/data/838879/000121390013003078/f8k061113ex10i_radientpharm.htm


1.5 “Licensed Patents and Pending Patents” means the patents listed in Exhibit A and any (i) continuation, divisional, continuation-in-part, reissue, extension, renewal, re-examination, and substitute thereof; (ii) foreign patent or patent application, including any foreign patent or patent application claiming priority to or otherwise constituting a counterpart of the patents listed in Exhibit A; and (iii) patent issuing from such applications in any country.

1.6 “Licensed Products” means the Onko-Sure and DR-70 kits and all Patents and Trademarks listed in Exhibit A, which may be updated from time to time upon the mutual written consent of the Parties.

As a little reminder
by dcspka • 3 hours ago

UniPharma has great expectations for DR-70/Onko-Sure.

"Since 2013, Uni Pharma successfully in-licensed DR-70®ELISA Test from USA and co-developed with Pharmigene. With great effort from Uni Pharma and Pharmigene, Taiwan-made DR-70®test passed TFDA and SGS audit and proudly received GMP and ISO 13485 certificate in March 2014. Furthermore, DR-70®receives Taiwan FDA marketing approval in August 2014 and CE certificate in September 2014.

DR-70®( licensed by Uni Pharma is approved by US FDA for colorectal cancer monitoring in 2008 and it is the only tumor marker approved for colorectal cancer monitoring by FDA since 1985. Serial testing using the DR-70®(by measure the concentration of Fibrin/fibrinogen degradation products, FDP) is to use as an aid in monitoring disease progression and treatment evaluation. Through its high accuracy, DR-70® has helped numerous clinical physicians and their patients worldwide.

Uni Pharma has noticed the medical advancement for cancer monitoring and therapies in Asia. The economic growth and increasing ratio of health related consumptions to GDP also encourages Uni Pharma takes its distributionship of DR-70® (in Taiwan to the next level and establishes a manufacturing site for Asia region. This allows Unipharma to ensure the supply chain and cold chain quality of DR-70® test to cover Asia-Pacific countries. Up to date, Uni Pharma has already exported DR-70® to India and Turkey. Other countries like Korea, China are under regulatory filing and expect to receive approval by Q4 2015 and 2017, respectively."

From an operational perspective, we continue to sell and ship Onko-Sure test kits to the following territories: Korea, Turkey, Taiwan, India, Vietnam, and the U.S. Despite significant financial hardship, the Company continues to maintain its operations in Tustin, relying on selective former employees that continue to work as consultants to the Company. We are also engaged in business discussions with other companies seeking to license Onko-Sure for various international territories. These licensing agreements, if completed, are anticipated to provide the Company with the funds necessary to regain compliance with our public filing requirements and to begin to pay down various overdue accounts payable. There can be no guarantee that any new licensing transactions will be completed.


http://www.sec.gov/Archives/edgar/data/838879/000114420412054967/v325211_8ka.htm



livinginsv Sunday, 07/26/15 10:51:34 PM
Re: guardiangel post# 29592
Post # of 29593

no waiting on UNI . . .

it looks like their doing fine . . . notice the DR70 and chinese writing on the labels . . . UNI is manufacturing already . . . and provista doesn't use DR70 anyway . . . check their site for proof . . . all ASU biomarkers, Videssa is the trademark . . .